Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer with PD-L1 ≥ 1 %: A subgroup analysis from the EMPOWER-Lung 3 part 2 trial
Titel:
Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer with PD-L1 ≥ 1 %: A subgroup analysis from the EMPOWER-Lung 3 part 2 trial
Auteur:
Baramidze, Ana Makharadze, Tamta Gogishvili, Miranda Melkadze, Tamar Giorgadze, Davit Penkov, Konstantin Laktionov, Konstantin Nemsadze, Gia Nechaeva, Marina Rozhkova, Irina Kalinka, Ewa AG McIntyre, Debra Perez, Javier Kaul, Manika Quek, Ruben G.W. Seebach, Frank Rietschel, Petra Pouliot, Jean-Francois